Azaspirene, a novel angiogenesis inhibitor, is based on the 1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione framework. Previous studies have shown that Azaspirene effectively inhibits VEGF-induced migration of human umbilical vein endothelial cells (HUVEC), demonstrating a potentially effective dosage. Moreover, azaspirene analogs may exhibit potential antitumor effects against uterine adenocarcinoma, possibly through significant anti-angiogenic activity.
Molecular Weight:
369.41
CAS Number:
[461644-34-8]
Formula:
C21H23NO5
Target:
VEGFR|||Raf
T202171
* VAT and and shipping costs not included. Errors and price changes excepted
